Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

IDH1 mutation is associated with lower expression of VEGF but not microvessel formation in glioblastoma multiforme.

Polívka J Jr, Pešta M, Pitule P, Hes O, Holubec L, Polívka J, Kubíková T, Tonar Z.

Oncotarget. 2018 Feb 20;9(23):16462-16476. doi: 10.18632/oncotarget.24536. eCollection 2018 Mar 27.

2.

The Effectiveness of Febrile Neutropenia Prophylaxis with Lipegfilgrastim in Routine Clinical Practice.

Holubec L, Polivka J, Lisnerova L, Kubikova T, Safanda M.

In Vivo. 2017 May-Jun;31(3):303-306. Review.

3.

Evaluation of Tumor Markers and Their Impact on Prognosis in Gallbladder, Bile Duct and Cholangiocellular Carcinomas - A Pilot Study.

Liska V, Treska V, Skalicky T, Fichtl J, Bruha J, Vycital O, Topolcan O, Palek R, Rosendorf J, Polivka J, Holubec L.

Anticancer Res. 2017 Apr;37(4):2003-2009.

PMID:
28373474
4.

Advances in Experimental Targeted Therapy and Immunotherapy for Patients with Glioblastoma Multiforme.

Polivka J Jr, Polivka J, Holubec L, Kubikova T, Priban V, Hes O, Pivovarcikova K, Treskova I.

Anticancer Res. 2017 Jan;37(1):21-33. Review.

PMID:
28011470
5.

Pre-transplant Quantitative Determination of NPM1 Mutation Significantly Predicts Outcome of AIlogeneic Hematopoietic Stem Cell Transplantation in Patients with Normal Karyotype AML in Complete Remission.

Karas M, Steinerova K, Lysak D, Hrabetova M, Jungova A, Sramek J, Jindra P, Polivka J, Holubec L.

Anticancer Res. 2016 Oct;36(10):5487-5498.

PMID:
27798920
6.

The Role of Cetuximab in the Induction of Anticancer Immune Response in Colorectal Cancer Treatment.

Holubec L, Polivka J Jr, Safanda M, Karas M, Liska V.

Anticancer Res. 2016 Sep;36(9):4421-6. Review.

PMID:
27630277
7.

Patient-reported outcomes with lanreotide Autogel/Depot for carcinoid syndrome: An international observational study.

Ruszniewski P, Valle JW, Lombard-Bohas C, Cuthbertson DJ, Perros P, Holubec L, Delle Fave G, Smith D, Niccoli P, Maisonobe P, Atlan P, Caplin ME; SYMNET study group.

Dig Liver Dis. 2016 May;48(5):552-558. doi: 10.1016/j.dld.2015.12.013. Epub 2016 Jan 15.

8.

G12V and G12A KRAS mutations are associated with poor outcome in patients with metastatic colorectal cancer treated with bevacizumab.

Fiala O, Buchler T, Mohelnikova-Duchonova B, Melichar B, Matejka VM, Holubec L, Kulhankova J, Bortlicek Z, Bartouskova M, Liska V, Topolcan O, Sedivcova M, Finek J.

Tumour Biol. 2016 May;37(5):6823-30. doi: 10.1007/s13277-015-4523-7. Epub 2015 Dec 10.

PMID:
26662311
9.

Tissue Biomarkers in Predicting Response to Sunitinib Treatment of Metastatic Renal Cell Carcinoma.

Trávníček I, Branžovský J, Kalusová K, Hes O, Holubec L, Pele KB, Ürge T, Hora M.

Anticancer Res. 2015 Oct;35(10):5661-6.

PMID:
26408740
10.

The Association of Serum Carcinoembryonic Antigen, Carbohydrate Antigen 19-9, Thymidine Kinase, and Tissue Polypeptide Specific Antigen with Outcomes of Patients with Metastatic Colorectal Cancer Treated with Bevacizumab: a Retrospective Study.

Fiala O, Finek J, Buchler T, Matejka VM, Holubec L, Kulhankova J, Bortlicek Z, Liska V, Topolcan O.

Target Oncol. 2015 Dec;10(4):549-55. doi: 10.1007/s11523-015-0365-x.

PMID:
25875421
11.

[Deferred breast reconstruction - soul surgery?].

Kydlíček T, Třešková I, Třeška V, Holubec L.

Cas Lek Cesk. 2013;152(6):267-73. Czech.

PMID:
24304037
12.

The role of cetuximab in the treatment of metastatic colorectal cancer.

Holubec L, Liska V, Matejka VM, Fiala O, Dreslerova J, Mrazkova P, Treska V, Finek J.

Anticancer Res. 2012 Sep;32(9):4007-11. Review.

PMID:
22993351
13.

Functional, genetic, and epigenetic aspects of base and nucleotide excision repair in colorectal carcinomas.

Slyskova J, Korenkova V, Collins AR, Prochazka P, Vodickova L, Svec J, Lipska L, Levy M, Schneiderova M, Liska V, Holubec L, Kumar R, Soucek P, Naccarati A, Vodicka P.

Clin Cancer Res. 2012 Nov 1;18(21):5878-87. doi: 10.1158/1078-0432.CCR-12-1380. Epub 2012 Sep 10.

14.

Infiltration of colorectal carcinoma by S100+ dendritic cells and CD57+ lymphocytes as independent prognostic factors after radical surgical treatment.

Liska V, Vycital O, Daum O, Novak P, Treska V, Bruha J, Pitule P, Holubec L.

Anticancer Res. 2012 May;32(5):2129-32.

PMID:
22593500
15.

Tumour necrosis factor-alpha stimulates liver regeneration in porcine model of partial portal vein ligation.

Liska V, Treska V, Mirka H, Kobr J, Sykora R, Skalicky T, Sutnar A, Bruha J, Fiala O, Vycital O, Chlumska A, Holubec L, Kormunda S, Trefil L, Racek J, Matejovic M.

Hepatogastroenterology. 2012 Mar-Apr;59(114):496-500. doi: 10.5754/hge10265.

PMID:
22353515
16.

Inhibition of transforming growth factor beta-1 augments liver regeneration after partial portal vein ligation in a porcine experimental model.

Liska V, Treska V, Mirka H, Kobr J, Sykora R, Skalicky T, Sutnar A, Vycital O, Bruha J, Pitule P, Chlumska A, Racek J, Benes J, Holubec L.

Hepatogastroenterology. 2012 Jan-Feb;59(113):235-40. doi: 10.5754/hge10116.

PMID:
22251543
17.

Prognostic significance of TIMP-1 in non-small cell lung cancer.

Pesta M, Kulda V, Kucera R, Pesek M, Vrzalova J, Liska V, Pecen L, Treska V, Safranek J, Prazakova M, Vycital O, Bruha J, Holubec L, Topolcan O.

Anticancer Res. 2011 Nov;31(11):4031-8.

PMID:
22110238
18.

Vitamin D in colorectal, breast, prostate and lung cancer: a pilot study.

Pazdiora P, Svobodova S, Fuchsova R, Kucera R, Prazakova M, Vrzalova J, Narsanska A, Strakova M, Treskova I, Pecen L, Treska V, Holubec L Jr, Pesek M, Finek J, Topolcan O.

Anticancer Res. 2011 Oct;31(10):3619-21.

PMID:
21965787
19.

New clinical scoring system for prognosis of early recurrence of colorectal liver metastases after surgical treatment.

Alan S, Vaclav L, Martin P, Vladislav T, Ondrej T, Tomas S, Stanislav K, Lubos H.

Hepatogastroenterology. 2011 Jul-Aug;58(109):1286-90. doi: 10.5754/hge10045.

PMID:
21937396
20.

The role of MonoTotal in the primary diagnosis, prognosis and follow-up of patients with non-small cell lung cancer (NSCLC).

Prazakova M, Vrzalova J, Auge JM, Safranek J, Topolcan O, Fuchsova R, Spisakova M, Svobodova S, Holubec L Jr, Pesta M.

Anticancer Res. 2011 Sep;31(9):3107-12.

PMID:
21868567

Supplemental Content

Loading ...
Support Center